Harvard Ave Acquisition Corp (HAVA) Stock Analysis

AI analysis of Harvard Ave Acquisition Corp (HAVA)

Hold

Currently, HAVA is not a strong buy. The stock is trading at $10.27, which is close to its 52-week high of $10.32, indicating limited upside potential. The RSI is at 51.39, suggesting the stock is neither overbought nor oversold. While the company has shown a positive trend in net income with a significant increase to $1,135,236 in Q1 2026, the forward P/E ratio is 0, indicating uncertainty in future earnings. The main risk is the high price-to-book ratio of 2279.89, which suggests that the stock may be overvalued relative to its book value.

Valuation Metrics

The current forward P/E ratio for Harvard Ave Acquisition Corp (HAVA) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued

5Y Average P/E

0.00

Current P/E

0.00

Overvalued

0.00

Undervalued

0.00

Forward EV/EBITDA

Strongly Undervalued

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued

0.00

Undervalued

0.00

Forward P/S

Strongly Undervalued

5Y Average P/S

0.00

Current P/S

0.00

Overvalued

0.00

Undervalued

0.00

Whales holding HAVA

W

Whitebox Advisors LLC

+ HoldingHAVA

-8.02%

3M Return

HAVA FAQ — answered by Alphio AI

Harvard Ave Acquisition Corp is a company formed for the sole purpose of merging with existing corporations. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company does not intend to limit its search for a target business to any particular industry or geographic location. It operates in the Financials sector.

Currently, HAVA is not a strong buy. The stock is trading at $10.27, which is close to its 52-week high of $10.32, indicating limited upside potential. The RSI is at 51.39, suggesting the stock is neither overbought nor oversold. While the company has shown a positive trend in net income with a significant increase to $1,135,236 in Q1 2026, the forward P/E ratio is 0, indicating uncertainty in future earnings. The main risk is the high price-to-book ratio of 2279.89, which suggests that the stock may be overvalued relative to its book value.